Logo
x

Search

Subscribe Now

All Posts by Date

BioMarin’s Voxzogo (vosoritide) Receives US FDA’s Approval for the Treatment of Childrens with Achondroplasia

BioMarin’s Voxzogo (vosoritide) Receives US FDA’s Approval for the Treatment of Childrens with Achondroplasia

  • November 19, 2021
Novo Nordisk to Acquire Dicerna for ~$3.3B

Novo Nordisk to Acquire Dicerna for ~$3.3B

  • November 19, 2021
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma

  • November 19, 2021
Gilead Exercises its Options with Arcus for its Three Clinical-Stage Programs to Treat Cancers

Gilead Exercises its Options with Arcus for its Three Clinical-Stage Programs to Treat Cancers

  • November 19, 2021
Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

  • November 19, 2021
Antengene's Selinexor (ATG-010) Receives NMPA's IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Antengene's Selinexor (ATG-010) Receives NMPA's IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

  • November 19, 2021
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.